GLP-1 receptor agonist: Clinical Trials

3 trials of GLP-1 receptor agonist, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 21Completed 1

Follow GLP-1 receptor agonist: new trials by email Literature Review of GLP-1 receptor agonist trials Research Report on GLP-1 receptor agonist

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy
GLP-1 receptor agonist, Placebo - Type 2 Diabetes Mellitus (T2DM)
Phase 3CompletedPegBio Co., Ltd.6202020-06-232023-07-28
Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects
GLP-1 receptor agonist, Placebo - Type 2 Diabetes Mellitus (T2DM)
Phase 3CompletedPegBio Co., Ltd.2732020-04-272023-07-28
Treating PCOS With Semaglutide vs Active Lifestyle Intervention
Semaglutide 3mg and 7mg [Rybelsus], Weight loss diet - PCOS, Adolescent Obesity
Phase 2 / Phase 3CompletedUniversity of Colorado, Denver602019-05-032025-11-25

Conditions studied

Diabetes Mellitus, Type 2 (2)  ·  Insulin Resistance (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Pediatric Obesity (1)

Sponsors

PegBio Co., Ltd. (2)  ·  University of Colorado, Denver (1)

Countries

China (2)  ·  United States (1)

Top investigators

Bin Gao, MD,PhD (1)  ·  Bin Gao, MD,PhD (1)  ·  Guixia Wang, MD,PhD (1)  ·  Hui Liu, MD,PhD (1)  ·  HuiMin Zhou, MD,PhD (1)  ·  Huige Shao, MD,PhD (1)  ·  Huige Shao, MD,PhD (1)  ·  Jianhua Ma, MD,PhD (1)  ·  Jianhua Ma, MD,PhD (1)  ·  Jiarui Li, MD,PhD (1)  ·  Jing Yang, MD,PhD (1)  ·  Jing Yang, MD,PhD (1)  ·  Jingna Lin, MD,PhD (1)  ·  Jingna Lin, MD,PhD (1)  ·  Lan Xu, MD,PhD (1)

Results publications

PMID 38948164, PMID 42014131

NIH funding

R01DK120612 (1)